177-Lu labeled peptide for site-specific uPAR-targeting
Grant
US12589171B2
Kind: B2
Mar 31, 2026
Assignee
TRT INNOVATIONS APS
Inventors
Andreas Kjaer, Morten Persson, Michael Ploug
Abstract
There is provided a 177-Lu labelled peptide for site-specific targeting of the Urokinase Plasminogen Activator Receptor (uPAR) thereby enabling treatment of a cancer disease associated with high uPAR expression; e.g. treatment of colorectal cancer by administering to a patient an effective amount of the 177-Lu labelled peptide.
CPC Classifications
A61K 51/00
A61K 51/08
A61K 51/088
A61K 2121/00
A61K 2123/00
C07K 16/2896
C07K 16/18
C12N 9/6465
C12N 9/72
A61P 35/00
Filing Date
2021-01-07
Application No.
17144067
Claims
9